Professional Documents
Culture Documents
A Comprehensive
Approach
By Troy Fugate and David B. LaTart
INTRODUCTION
Now that the Food and Drug Administration (FDA) has decided to con-
duct inspections according to quality systems, it seems only prudent for
pharmaceutical operations to re-evaluate their cleaning system and its
policies and procedures. Cleaning seems simple enough; however, upon
closer examination, the system of cleaning is complex and inter-related
with several other functions in various areas. This paper is intended to
explore those relationships, to enable readers to evaluate their cleaning
systems for compliance with FDA Code of Federal Regulations (CFR) 21,
Parts 210 and 211, and to offer a comprehensive approach to establishing
an effective system.
Cleaning Validation 23
Troy Fugate and David B. LaTart
Documentation
Validation
You must validate your cleaning process and the analytical methods
that support it.
Change Control
People
Material
Design
How well designed is the equipment to facilitate its cleaning? Are there
difficult to access nooks and crannies? Can it easily be cleaned manually,
if necessary?
Construction
Are the welds good? Is the equipment passivated that is, are its sur-
faces treated to ensure adequate cleanability and to prevent decay?
Piping should have a minimum of threading to reduce inevitable build-up
of material around threads material that could contaminate the next
material that might flow through the pipe. Does the construction limit or
impede cleaning?
Maintenance
Cleaning Validation 25
Troy Fugate and David B. LaTart
Hold Times
the worst case, thus ensuring that all of the lesser cases are
accommodated as well.
Develop and validate analytical methods to detect and measure the
analyte (residual active ingredient, residual soap, etc.).
Cleaning Validation 27
Troy Fugate and David B. LaTart
Figure 1
A Cross-Systems Approach to Cleaning
People
Componen
nts Storag
age
SOP Doc
ocu
cumen
ent
C
Fac
acilities
es Equipment
nt
V alidat
ae
C = Compliance
Facilities
Equipment
People
People are involved in all of the activities that go into the other three
cross-functional elements. They must follow gowning and operating proce-
dures. They are responsible for activities such as cleaning as well as for
documenting those cleaning activities. In addition, training records for all
personnel must be complete and current.
Cleaning Validation 29
Troy Fugate and David B. LaTart
BENCHMARKING A CLEANING
PROGRAM
To develop and implement a compliant cleaning program, a cleaning
team composed of representatives familiar with each of the six systems
should be brought together. As they develop the cleaning program, they
should benchmark it against regulations and a cleaning standard. Once
the program is in place, the team should review it periodically to ensure its
effectiveness and its level of compliance.
Written Program
A Written Program Must Be in Place
Equipment
Equipment Must Be Evaluated for Cleanability
Equipment
Worst-case Approach
Cleaning Validation 31
Troy Fugate and David B. LaTart
procedure is used.
A rationale must be documented and proven when selecting this
cleaning validation approach.
Calculations
Perform Dose, Toxicity, and Weight Percent Calculations
CONCLUSION:
A COMPLIANT PROGRAM
A compliant cleaning program results when you address all of its sys-
temic elements, understand their interdependence, and complete activities
across the multiple quality systems. Once you have defined the relevant
regulations, identified critical issues and activities, and created an
approach to establish and maintain a cleaning program of quality, you
must continue to maintain and improve it.
Cleaning Validation 33
Troy Fugate and David B. LaTart
REFERENCES
1. Draft Guidance: Guidance for Industry Quality Systems Approach to Pharmaceutical
Current Good Manufacturing Practice Regulations, FDA, September 2004.
2. Guide to Inspections Validation of Cleaning Processes, FDA Website, ORA, July 2004.
Originally published in the July 2005 issue of the Journal of GXP Compliance
Cleaning Validation 35
Troy Fugate and David B. LaTart
The FDA provides specific regulations for cleaning four of the systems
described in the GMP quality system model: quality, facilities and equip-
ment, materials, and packaging and labeling. The regulations do not
clearly specify cleaning for the laboratory controls or the production sys-
tems. Explicit regulations for each of the four systems described therein
include:
QUALITY
21 CFR Part 211.28 Personnel Responsibilities
Protective apparel
Practice of good sanitation and
health habits
Limited access to clean areas
Report necessary health conditions
21 CFR Part 211.182 Documentation
Records of major equipment cleaning
MATERIALS
Cleaning Validation 37